Standardization and development of Pasteurella multocida inactivated adjuvanted vaccine against septic pasteurellosis in pigs

被引:0
作者
Verma, Harshit [1 ]
Rawat, Mayank [1 ]
Samal, Ashabaree [1 ]
Upmanyu, Vikramaditya [1 ]
Durairajan [1 ]
Verma, Rishendra [1 ]
机构
[1] IVRI, Div Biol Standardizat, Izatnagar 243122, Uttar Pradesh, India
关键词
Haemorrhagic septicaemia; Homologus Pig strain; Piggery; Soron; Sus scrofa domesticus; Swine; HEMORRHAGIC SEPTICEMIA; STRAINS; RESPONSES; ASSAY;
D O I
暂无
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
In piggery, septic pasteurellosis caused by Pasteurella multocida (B:2) is an issue of concern, which needs an effective vaccine. Here, we prepared a double emulsified (DE) vaccine containing 2.5 mg inactivated antigenic mass of pig field strain (B:2) (named as soron) isolated from an outbreak of septicaemic death in pigs and P. multocida P-52 cattle strain (B:2) and studied their efficiency in terms of immunity to direct challenge, duration of immunity and the role of humoral and cell-mediated immunity. Both of these strains showed presence of hgbB, pfhA, nanH, ptfA, and tbPA virulence genes. The sequence analysis of bands of 760 bp product using capsular primers were obtained for soron and P-52 revealed 99.2% homology between these two strains, indicating differences at genetic level. nanH and pfhA genes of soron shared 99.2% and 92.7% homology with P-52, respectively suggesting differences between these two strains at genetic level. SDS-PAGE analysis of cell wall of both strains showed presence of about 15 major protein bands whereas Western blot analysis with 21 day soron immunized pig serum showed 16, 33, 47, 63 and 83 kDa polypeptides in both strains. The duration of immune responses were monitored at 3, 6 and 9 months post immunization in pigs. By direct challenge, pigs showed that the vaccines were protective at 21 days and up to 270th day post immunization. Vaccines induced a serum ELISA IgG response that peaked on 60 DPI which declined gradually up to 270th DPI in both vaccines. Stimulation index measured by lymphocyte proliferation test (LTT) indicated that the vaccine, induced cell-mediated immune response and in general percent stimulation index (SI) was higher in pigs immunized with soron vaccine at 15 days post challenge infection. The results showed that pig strain (soron) would be a potential homologous strain of P. multocida for the vaccine against pasteurellosis in place of use of cattle P. multocida P-52 strain.
引用
收藏
页码:315 / 323
页数:9
相关论文
共 32 条
  • [1] Bain RVS, 1982, 33 FAO UN
  • [2] AN ENZYME-LINKED IMMUNOSORBENT-ASSAY FOR DETECTING ANTIBODIES TO PASTEURELLA-MULTOCIDA IN CHICKENS
    BRIGGS, DJ
    SKEELES, JK
    [J]. AVIAN DISEASES, 1984, 28 (01) : 208 - 215
  • [3] Chandler H M, 1976, Dev Biol Stand, V32, P137
  • [4] Chandrashekaran S, 1991, FAO APHCA PUBLICATIO, V13, P124
  • [5] Virulence genotype of Pasteurella multocida strains isolated from different hosts with various disease status
    Ewers, Christa
    Luebke-Becker, Antina
    Bethe, Astrid
    Kiessling, Sabine
    Filter, Matthias
    Wieler, Lothar H.
    [J]. VETERINARY MICROBIOLOGY, 2006, 114 (3-4) : 304 - 317
  • [6] Ghosh R. C., 2011, Indian Journal of Veterinary Pathology, V35, P87
  • [7] Pasteurella multocida pathogenesis:: 125 years after Pasteur
    Harper, Marina
    Boyce, John D.
    Adler, Ben
    [J]. FEMS MICROBIOLOGY LETTERS, 2006, 265 (01) : 1 - 10
  • [8] PROTECTIVE EFFECTS OF PASSIVELY TRANSFERRED IMMUNE T-LYMPHOCYTES OR B-LYMPHOCYTES IN MICE INFECTED WITH SALMONELLA-TYPHIMURIUM
    HOCHADEL, JF
    KELLER, KF
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1977, 135 (05) : 813 - 823
  • [9] Adjuvant activity of Pasteurella multocida A strain, Pasteurella multocida B strain and Salmonella typhimurium bacterial DNA on cellular and humoral immunity responses against Pasteurella multocida specific strain infections in Balb/c mice
    Homayoon, Maryam
    Tahamtan, Yahya
    Kargar, Mohammad
    Hosseini, Seyed Mohammad Hossein
    Sepahy, Abbas Akhavan
    [J]. ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2018, 11 (05) : 336 - 341
  • [10] Indian Pharmacopoeia Commission Indian Pharmacopoeia, 2010, IND PHARM